The Pharmaceutical Working Group is comprised of 38 foreign pharmaceutical manufacturing companies. All members are committed to cooperating closely with Chinese healthcare stakeholders, in order to establish a competitive healthcare system which serves all Chinese patients. As such, the Working Group strongly welcomes the initiatives made for the long-term, which will substantially benefit both Chinese patients and the Chinese economy. The technology transferred from Europe further demonstrates the commitment these companies make in supporting China's goal to become an innovative society by 2020.
Shanghai Bracco Sine Pharmaceutical Corp. Ltd.